Frederick, MD · Founded 2017 · Privately Held (backing)
Developer of small molecule therapeutics designed to target heparin-induced thrombocytopenia and thrombosis. Veralox Therapeutics is based in Frederick, MD and was founded in 2017. It was valued at $66 million at its later-stage round in Jun 2023, the last priced event on record. It has raised $41.2 million across 3 recorded rounds; the latest was a $24 million early-stage round in Jun 2023.
PMV mark · valuation
$66.0M
Oct 2026
Priced at
its later-stage round
Jun 2023
Total raised
$41.2M
Last round
Early Stage VC
Jun 2023
Team — not yet on record
No current team members for Veralox Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Veralox Therapeutics with a free account
·The complete investor list: 15 names
·Watch Veralox Therapeutics: the Monday email on marks, rounds and moves
